CLASS II Device recall · Reported 1 Feb 2017 · FDA Enforcement Report

Merge Hemo recalled by Merge Healthcare

Merge Healthcare is recalling Merge Hemo, distributed nationwide in the US. The recall was initiated on 28 Mar 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesVersions 6.10, 6.10.1, 6.10.2, 6.10.3, 7.10, 7.20, 7.20.1, 8.10.0, 8.20, 9.10.0, 9.20, 9.20.2, 9.20.3, 9.30, 9.40, 9.40.1, 9.40.2, and 9.40.3
Quantity recalled242 sites potentially have the affected versions

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1091-2017
FDA event ID
76214
Recalling firm
Merge Healthcare, Hartland, WI
Classification
Class II
Status
Terminated
Recall initiated
28 Mar 2016
FDA classified
24 Jan 2017
Reported
1 Feb 2017
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Device Malfunction

Timeline

28 Mar 2016Recall initiated by company
24 Jan 2017Classified by FDA+302 days
1 Feb 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a potential connection issue when powering up the Merge Hemo Record Station and the Hemo Monitor does not communicate with the Client PC.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Merge Hemo software. Merge Hemo monitors, measures, and records physiologic data from a human patient undergoing a cardiac catheterization procedure

Where it was distributed

Nationwide Distribution

Nationwide

Questions about this recall

Is Merge Hemo recalled?

Yes. Merge Healthcare recalled Merge Hemo on 28 Mar 2016. The recall is Class II and its status is Terminated. Recall number Z-1091-2017.

Why was it recalled?

There is a potential connection issue when powering up the Merge Hemo Record Station and the Hemo Monitor does not communicate with the Client PC.

Which lots are affected?

Versions 6.10, 6.10.1, 6.10.2, 6.10.3, 7.10, 7.20, 7.20.1, 8.10.0, 8.20, 9.10.0, 9.20, 9.20.2, 9.20.3, 9.30, 9.40, 9.40.1, 9.40.2, and 9.40.3

Where was it sold?

Nationwide Distribution

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Merge Healthcare

All 96

Other Heart & Vascular Devices recalls

All 6,199